1. Update on invasive opportunistic mycoses: Clinical trials review, 2008–2009

   • Andreas H. Groll

   OriginalPaper 06 November 2009 Pages: 417 - 419

2. Risk-based antifungal prophylaxis in hematologic malignancy and stem cell transplantation

   • Joshua Wolf
   • Monica A. Slavin

   OriginalPaper 06 November 2009 Pages: 420 - 426

3. Prophylaxis of invasive mycoses in solid organ transplantation

   • Kyle P. Radack
   • Barbara D. Alexander

   OriginalPaper 06 November 2009 Pages: 427 - 434

4. New immunosuppressive agents and risk for invasive fungal infections

   • Georg Maschmeyer
   • Thomas F. Patterson

   OriginalPaper 06 November 2009 Pages: 435 - 438

5. What is the role of therapeutic drug monitoring in antifungal therapy?

   • Jeannina A. Smith

   OriginalPaper 06 November 2009 Pages: 439 - 446

6. Genitourinary manifestations of Epstein-Barr virus infections

   • Randi Leigh
   • Paul Nyirjesy

   OriginalPaper 06 November 2009 Pages: 449 - 456

7. New concepts in understanding genital herpes

   • Joshua T. Schiffer
   • Lawrence Corey

   OriginalPaper 06 November 2009 Pages: 457 - 464

8. MRSA infection of buttocks, vulva, and genital tract in women

   • Orna Reichman
   • Jack D. Sobel

   OriginalPaper 06 November 2009 Pages: 465 - 470

9. Antibiotic consideration in bacterial vaginosis

   • Jack D. Sobel

   OriginalPaper 06 November 2009 Pages: 471 - 475

10. HIV and the kidney

    • Leslie A. Bruggeman
    • Charles Bark
    • Robert C. Kalayjian

    OriginalPaper 06 November 2009 Pages: 479 - 485

11. Update on immune reconstitution inflammatory syndrome: Progress and unanswered questions

    • Colleen F. Kelley
    • Wendy S. Armstrong

    OriginalPaper 06 November 2009 Pages: 486 - 493